Mankind Pharma, the fourth largest pharmaceutical manufacturing company headquartered in India has entered a collaboration with Accenture to accelerate its journey of digital transformation, improving business and operational efficiency.
Accenture has redesigned Mankind Pharma’s business processes across key functions such as finance, supply chain, sales and procurement for better optimaisation, demand planning, workforce productivity and product availability.
As a part of this venture, Accenture has also deployed a digital platform which is based on SAP S/4HANA®, a Microsoft Azure cloud-based data lake and Tableau dashboards, providing cloud-based analytics to help Mankind Pharma gain better insights into its global business operations and performance. The platform integrates data in real-time from multiple sources across the supply chain, workforce and sales to provide a consolidated view of market insights. This will help the management team make informed decisions around the business strategy, planning and product development, the company said.
This project was completed remotely during the ongoing COVID19 pandemic without impacting on the continuity of the business.
“At Mankind Pharma, we are committed to product innovation so we can provide high quality and affordable pharmaceutical products to people across the world. Digitally transforming our business processes with support from Accenture has been key to unlocking value trapped within the organization, accelerating real time decision making, and improving our product innovation lifecycle”, said Arjun Juneja, chief operating officer, Mankind Pharma.
“Digital reinvention can not only help pharma companies deliver high-quality and hyper-personalized services, but also improve business performance and build resilience against future disruptions. We are focused on helping Mankind Pharma embrace change and emerge as a data-driven enterprise to enhance its customer-centricity bringing innovative offerings to market at a faster pace and scale for patients”, said Rishabh Bindlish, India Life Sciences and global generics lead, Accenture.
